GCTK Glucotrack, Inc.

BEARISH Impact: 8/10 8-K
Horizon weeks Filed May 15, 2026 Processed 28d 15h ago SEC 0001493152-26-023889
8-K context-dependent: Items 3.01
Latest settled — T+5d ⚠ clustered
GCTK ▲ +23.19% at T+5d
SHORT call ✗ call lost -23.19% · α vs SPY -21.57% · entry $0.4830 → $0.5950
Next anchor: T+20d tomorrow
Currently $0.3860 · +20.08% from $0.4830 entry (call sign-flipped)
Entry anchored
May 15, 2026
via day open
T+1d
+14.91%
call -14.91% · α -15.56%
$0.5550
settled 26d ago
T+5d
+23.19%
call -23.19% · α -21.57%
$0.5950
settled 22d ago
T+20d
call — · α —
tomorrow
T+60d
call — · α —
in 8w

Price Chart

Loading chart...

Executive Summary

Glucotrack received two Nasdaq deficiency notices: one for failing the $1.00 minimum bid price rule and a second for failing the $2.5 million minimum stockholders' equity requirement. The company faces imminent delisting risk, with a hearing requested to appeal but no guarantee of success. The $1M market cap micro-cap is now fighting to stay listed on Nasdaq.

Actionable Insight

Monitor the Nasdaq hearing outcome in the coming weeks. If delisting occurs, expect a sharp price decline and reduced trading volume. Any reverse stock split or capital raise plan to regain compliance could cause further dilution.

Key Facts

  • Nasdaq staff determined to delist GCTK for non-compliance with the $1.00 minimum bid price rule (Rule 5550(a)(2)).
  • A second deficiency was identified on May 15, 2026: stockholders' equity below the $2.5 million minimum (Rule 5550(b)(1)).
  • Company requested a hearing by May 18, 2026, which stays delisting through the hearing process.
  • No assurance of regaining compliance or continued listing; potential transfer to OTC markets.

Financial Impact

Potential loss of Nasdaq listing, which typically results in severe liquidity reduction and significant share price decline for micro-cap stocks.

liquiditystock priceinstitutional ownership

Risk Factors

  • Delisting from Nasdaq, forcing trading to OTC markets with lower liquidity and visibility.
  • Potential reverse stock split or dilutive equity offering to meet minimum bid price or equity requirements.
  • Inability to raise capital due to distressed financial condition and low market cap.

Market Snapshot

Exchange
Nasdaq
Sector
Surgical & Medical Instruments & Apparatus

Documents Analyzed

This report is based on 4 SEC documents filed with EDGAR.

DocumentAccession Number
8-K Filing (Primary)0001493152-26-023889
Document: 0001493152-26-023889-index-headers.html0001493152-26-023889
Document: 0001493152-26-023889-index.html0001493152-26-023889
Document: 0001493152-26-023889.txt0001493152-26-023889
8 reports for GCTK
Performance horizon

Track record builds as more directional reports settle.

Filters
Rows
Reports for GCTK — sortable, filterable
Type Now
May 15, 2026
28d ago
8-K
BEARISH ★ 8/10
$0.4830 $0.5950▼ −23.19%▼ −21.57%$0.3860 (+20.08%)
May 14, 2026
29d ago
8-K
NEUTRAL ★ 5/10
$0.6500 $0.5000▼ −23.08%▼ −24.04%$0.3860 (−40.62%)
May 7, 2026
5w ago
Press Release
NEUTRAL ★ 4/10
$0.8600 $0.7000▼ −18.60%▼ −20.11%$0.3860 (−55.12%)
Apr 30, 2026
6w ago
8-K
BEARISH ★ 7/10
$0.8000 $0.8600▼ −7.50%▼ −5.15%$0.3860 (+51.75%)
Apr 14, 2026
8w ago
8-K
BEARISH ★ 6/10
$0.7350 $0.7490▼ −1.90%▼ −0.51%$0.3860 (+47.48%)
Mar 30, 2026
10w ago
8-K
MIXED ★ 5/10
$0.6500 $0.6830▲ +5.08%▲ +1.13%$0.3860 (−40.62%)
Mar 30, 2026
10w ago
Press Release
MIXED ★ 5/10
$0.6500 $0.6830▲ +5.08%▲ +1.13%$0.3860 (−40.62%)
Mar 27, 2026
11w ago
Press Release
MIXED ★ 6/10
$0.9900 $0.8300▼ −16.16%▼ −20.02%$0.3860 (−61.01%)
Showing 8 of 8

US Market Status

Market Closed — Opens Mon (49h 30m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access